Swiss All Share Index

Swiss All Share Index handeln
17.970,97 PKT -10,34 PKT -0,06 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
22.04.05 Sulzer Buy Sarasin Research
21.04.05 Kühne + Nagel International Neutral Sarasin Research
21.04.05 Novartis Akkumulieren Independent Research
21.04.05 Roche Sector Outperform Vontobel
21.04.05 Nestlé Neutral Sarasin Research
25.04.05 Lindt Neutral Sarasin Research
21.04.05 Geberit Buy Sarasin Research
21.04.05 Novartis Buy Merrill Lynch
21.04.05 Roche Outperform Goldman Sachs
21.04.05 Novartis Neutral Sarasin Research
22.04.05 Novartis Kaufen Helaba Trust
20.04.05 Logitech In-Line Goldman Sachs
20.04.05 ARYZTA Sector Perform Vontobel
20.04.05 ABB (Asea Brown Boveri) Kaufen Helaba Trust
20.04.05 Nestlé Overweight JP Morgan
20.04.05 Roche Overweight JP Morgan
21.04.05 Logitech Neutral Sarasin Research
20.04.05 Nestlé In-Line Goldman Sachs
20.04.05 Roche Equal weight Lehman Brothers
20.04.05 Nestlé Kaufen Helaba Trust
20.04.05 Roche Outperform Goldman Sachs
20.04.05 Roche Buy Sarasin Research
25.04.05 Helvetia Baloise Neutral Sal. Oppenheim
19.04.05 BB Biotech Kaufen Hamburger Sparkasse
19.04.05 Novartis Buy Merrill Lynch
19.04.05 ABB (Asea Brown Boveri) Overweight JP Morgan
19.04.05 Roche Akkumulieren Independent Research
21.04.05 Novartis Underperform Credit Suisse First Boston
19.04.05 Roche Halten Helaba Trust
19.04.05 Roche Buy Sarasin Research
18.04.05 UBS Market Perform Vontobel
19.04.05 Clariant Neutral HypoVereinsbank
18.04.05 Helvetia Baloise Accumulate Helvea
18.04.05 Novartis Outperform Goldman Sachs
19.04.05 Roche Overweight JP Morgan
18.04.05 UBS Market Outperform Vontobel
18.04.05 Helvetia Baloise Sector Outperform Vontobel
19.04.05 Novartis Neutral JP Morgan
19.04.05 Roche Equal weight Lehman Brothers
18.04.05 Swiss Prime Site Neutral Sarasin Research